Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03367871
Title Combination Pembrolizumab, Paclitaxel and Cisplatin in Patients With Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Miami
Indications

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma

Therapies

Cisplatin + Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.